|
WO2021034034A1
|
|
Method for detecting chromosomal abnormality by using information about distance between nucleic acid fragments
|
|
KR20210021923A
|
|
Method for detecting chromosomal abnormality using distance information between nucleic acid fragments
|
|
KR20200101106A
|
|
Method for Prognosing Hepatic Cancer Patients Based on Circulating Cell Free DNA
|
|
KR20200034125A
|
|
Markers for predicting concentration of statin in blood
|
|
KR20200012530A
|
|
Method for Detecting Chromosomal Abnormalities Based on Whole Genome Sequencing and Uses thereof
|
|
KR20190085667A
|
|
Circulating Tumor DNA Detection Method Using Sample comprising Cell free DNA and Uses thereof
|
|
WO2018016884A1
|
|
Composition for diagnosing congenital functional disorder, and use thereof
|
|
KR20180001442A
|
|
Composition for detecting Birth Dysfunction and use thereof
|
|
KR20180001437A
|
|
Composition for detecting Birth Dysfunction and use thereof
|
|
KR20180009999A
|
|
Composition for detecting RASopathies and use thereof
|
|
KR20180010000A
|
|
Composition for detecting Inherited Blood Coagulation Disorders and use thereof
|
|
KR20180009998A
|
|
Composition for detecting Inborn Error of Metabolism and use thereof
|
|
KR101743211B1
|
|
Composition for detecting Birth Dysfunction and use thereof
|
|
KR101774996B1
|
|
Markers For Predicting Effect of Therapeutic Agent Against Hemophilia and Use Thereof
|
|
KR101686146B1
|
|
Copy Number Variation Determination Method Using Sample comprising Nucleic Acid Mixture
|
|
CN108475301A
|
|
The method of copy number variation in sample for determining the mixture comprising nucleic acid
|
